Sara Galuppo

Learn More
The management of breast cancer (BC) skin metastases represents a therapeutic challenge. Electrochemotherapy (ECT) combines the administration of bleomycin with temporary permeabilization induced by locally administered electric pulses. Preliminary experience with ECT in BC patients is encouraging. A total of 125 patients with BC skin metastases who(More)
To evaluate the efficacy and toxicity of electrochemotherapy (ECT) in elderly metastatic breast cancer (BC) patients. Retrospective analysis of 55 patients with superficial metastases who underwent ECT according to the European Standard Operative Procedures of electrochemotherapy. Treatment schedule consisted of intravenous or intratumoral bleomycin(More)
OBJECTIVES The aim of the study was to evaluate the prognostic value of F-fluorodeoxyglucose PET/computed tomography (CT) after neoadjuvant therapy (NAT) in locally advanced esophageal cancer (EC) patients. MATERIALS AND METHODS We recruited 79 EC patients from a sample of 210 who underwent F-fluorodeoxyglucose PET/CT after NAT and who did not have(More)
We read with interest Bourke et al.’s paper on the treatment of cutaneous metastases from breast cancer (BC) with electrochemotherapy (ECT) [1]. In a highly pretreated population—whose survival from the diagnosis of skin metastases was 36 months—ECT proved to be highly active, with only 25% of patients being non-responsive to treatment. Skin tumor(More)
Electrochemotherapy (ECT), by combining manageable cytotoxic agents with short electric pulses, represents an effective palliative skin-directed therapy. The accumulated evidence indicates that ECT stands out as a safe and well-tolerated alternative treatment for patients with multiple or large basal cell carcinoma (BCC), who are not suitable for(More)
  • 1